AbbVie
|
176.97 |
|
-2.11 |
-1.18% |
8.97% |
2025-04-15 |
Acadia Pharmaceuticals
|
14.99 |
|
0.13 |
0.87% |
-12.24% |
2025-04-15 |
Agios Pharmaceuticals
|
27.83 |
|
0.31 |
1.13% |
-3.37% |
2025-04-15 |
Alnylam Pharmaceuticals
|
230.71 |
|
-9.30 |
-3.87% |
57.25% |
2025-04-15 |
Amgen
|
295.44 |
|
1.74 |
0.59% |
11.24% |
2025-04-15 |
Arrowhead Research
|
12.85 |
|
0.51 |
4.13% |
-45.71% |
2025-04-15 |
Biogen
|
116.98 |
|
-2.23 |
-1.87% |
-40.58% |
2025-04-15 |
BioMarin Pharmaceutical
|
60.00 |
|
0.33 |
0.55% |
-33.97% |
2025-04-15 |
Bristol-Myers Squibb
|
49.97 |
|
-1.38 |
-2.69% |
3.50% |
2025-04-15 |
Gilead Sciences
|
105.65 |
|
-0.85 |
-0.80% |
56.91% |
2025-04-15 |
Incyte
|
58.46 |
|
-0.76 |
-1.28% |
9.76% |
2025-04-15 |
Insmed
|
71.01 |
|
-0.02 |
-0.03% |
171.55% |
2025-04-15 |
Ionis Pharmaceuticals
|
28.40 |
|
-0.28 |
-0.98% |
-31.63% |
2025-04-15 |
J&J
|
153.63 |
|
-0.61 |
-0.40% |
6.26% |
2025-04-15 |
Merck
|
78.23 |
|
-0.80 |
-1.01% |
-37.48% |
2025-04-15 |
Moderna
|
26.24 |
|
-0.52 |
-1.94% |
-74.75% |
2025-04-15 |
Neurocrine Biosciences
|
96.22 |
|
1.33 |
1.40% |
-27.65% |
2025-04-15 |
Novartis
|
90.20 |
|
1.46 |
1.65% |
6.12% |
2025-04-15 |
Pfizer
|
22.45 |
|
0.36 |
1.63% |
-12.65% |
2025-04-15 |
PTC Therapeutics
|
46.98 |
|
1.90 |
4.21% |
85.77% |
2025-04-15 |
Ultragenyx Pharmaceutical
|
35.34 |
|
0.42 |
1.20% |
-16.47% |
2025-04-15 |
Regeneron Pharmaceuticals
|
557.94 |
|
-12.67 |
-2.22% |
-37.57% |
2025-04-15 |
Roche Holding
|
255.40 |
|
3.70 |
1.47% |
15.30% |
2025-04-15 |
Sanofi
|
91.62 |
|
-0.26 |
-0.28% |
5.57% |
2025-04-15 |
Sarepta Therapeutics
|
54.42 |
|
-0.21 |
-0.38% |
-53.60% |
2025-04-15 |
United Therapeutics
|
284.70 |
|
0.39 |
0.14% |
22.83% |
2025-04-15 |
Vertex Pharmaceuticals
|
500.35 |
|
4.44 |
0.90% |
26.92% |
2025-04-15 |